Peter Goldman

8.7k total citations · 3 hit papers
127 papers, 6.5k citations indexed

About

Peter Goldman is a scholar working on Molecular Biology, Physiology and Infectious Diseases. According to data from OpenAlex, Peter Goldman has authored 127 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 19 papers in Physiology and 11 papers in Infectious Diseases. Recurrent topics in Peter Goldman's work include Gut microbiota and health (13 papers), Enzyme function and inhibition (11 papers) and Diet and metabolism studies (8 papers). Peter Goldman is often cited by papers focused on Gut microbiota and health (13 papers), Enzyme function and inhibition (11 papers) and Diet and metabolism studies (8 papers). Peter Goldman collaborates with scholars based in United States, United Kingdom and Malaysia. Peter Goldman's co-authors include Mark A. Peppercorn, P. Roy Vagelos, Steven R. Tannenbaum, Laura C. Green, Ted J. Kaptchuk, Ronald L. Koch, Catherine L. Drennan, Carl C. Levy, William B. Stason and David A. Stone and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Peter Goldman

126 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome

2008 833 citations Ted J. Kaptchuk, John M. Kelley et al. BMJ profile →
Nitrate Synthesis in the Germfree and Conventional Rat

1981 440 citations Peter Goldman et al. profile →
THE ROLE OF INTESTINAL BACTERIA IN THE METABOLISM OF SALICYLAZOSULFAPYRIDINE

1972 357 citations Peter Goldman et al. Journal of Pharmacology and Experimental Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Goldman United States	40	2.1k	791	760	697	632	127	6.5k
Felipe Dal‐Pizzol Brazil	69	3.4k 1.6×	546 0.7×	428 0.6×	1.5k 2.2×	1.2k 1.9×	419	15.3k
C. H. Gleiter Germany	18	1.5k 0.7×	363 0.5×	132 0.2×	588 0.8×	822 1.3×	46	6.3k
Laurie Goodman United States	29	1.5k 0.7×	150 0.2×	258 0.3×	597 0.9×	578 0.9×	104	6.5k
Jan Koch‐Weser United States	76	3.0k 1.4×	275 0.3×	438 0.6×	1.3k 1.8×	2.3k 3.7×	220	15.4k
Antonella Paladini Italy	36	1.1k 0.5×	376 0.5×	287 0.4×	861 1.2×	1.1k 1.8×	217	5.3k
R.C. Heel United States	67	2.1k 1.0×	158 0.2×	309 0.4×	1.1k 1.6×	1.7k 2.7×	111	10.9k
Salvatore Chirumbolo Italy	46	1.7k 0.8×	298 0.4×	774 1.0×	958 1.4×	489 0.8×	240	6.7k
Robert J. Williams United Kingdom	61	4.0k 1.9×	855 1.1×	242 0.3×	2.1k 3.0×	1.3k 2.0×	271	14.5k
Francesco Capasso Italy	49	1.8k 0.9×	1.0k 1.3×	410 0.5×	848 1.2×	2.7k 4.3×	167	9.1k
Takaaki Hasegawa Japan	36	1.5k 0.7×	172 0.2×	300 0.4×	1.2k 1.7×	867 1.4×	260	5.2k

Countries citing papers authored by Peter Goldman

Since Specialization

Citations

This map shows the geographic impact of Peter Goldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Goldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Goldman more than expected).

Fields of papers citing papers by Peter Goldman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Goldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Goldman. The network helps show where Peter Goldman may publish in the future.

Co-authorship network of co-authors of Peter Goldman

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Goldman. A scholar is included among the top collaborators of Peter Goldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Goldman. Peter Goldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grell, Tsehai A.J., Peter Goldman, & Catherine L. Drennan. (2014). SPASM and Twitch Domains in S-Adenosylmethionine (SAM) Radical Enzymes. Journal of Biological Chemistry. 290(7). 3964–3971. 133 indexed citations

Goldman, Peter, Katherine S. Ryan, Annaleise R. Howard‐Jones, et al.. (2012). An Unusual Role for a Mobile Flavin in StaC-like Indolocarbazole Biosynthetic Enzymes. Chemistry & Biology. 19(7). 855–865. 29 indexed citations

Kaptchuk, Ted J., John M. Kelley, Lisa Conboy, et al.. (2008). Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ. 336(7651). 999–1003. 833 indexed citations breakdown →

Greenblatt, David J., Lisa L. von Moltke, Yan Luo, et al.. (2006). Ginkgo biloba Does Not Alter Clearance of Flurbiprofen, a Cytochrome P450‐2C9 Substrate. The Journal of Clinical Pharmacology. 46(2). 214–221. 48 indexed citations

Kaptchuk, Ted J., Peter Goldman, David A. Stone, & William B. Stason. (2000). Do medical devices have enhanced placebo effects?. Journal of Clinical Epidemiology. 53(8). 786–792. 344 indexed citations

Goldman, Peter. (1997). Olestra: Assessing its potential to interact with drugs in the gastrointestinal tract. Clinical Pharmacology & Therapeutics. 61(6). 613–618. 11 indexed citations

Vickers, Andrew J., Barrie R. Cassileth, Edzard Ernst, et al.. (1997). How Should we Research Unconventional Therapies?A Panel Report from the Conference on Complementary and Alternative Medicine Research Methodology, National Institutes of Health. International Journal of Technology Assessment in Health Care. 13(1). 111–121. 70 indexed citations

Lai, Ronald & Peter Goldman. (1992). Urinary organic acid profiles in obese (ob/ob) mice: Indications for the impaired ω-oxidation of fatty acids. Metabolism. 41(1). 97–105. 8 indexed citations

Goldman, Peter, et al.. (1991). Effect of the intestinal flora on the urinary organic acid profile of rats ingesting a chemically simplified diet. Food and Chemical Toxicology. 29(2). 107–113. 7 indexed citations

10.

Ehlhardt, William J. & Peter Goldman. (1989). Thiol-mediated incorporation of radiolabel from 1-[14C]-methyl-4-phenyl-5-nitrosoimidazole into DNA a model for the biological activity of 5-nitroimidazoles. Biochemical Pharmacology. 38(7). 1175–1180. 6 indexed citations

11.

Ehlhardt, William J., Bernard B. Beaulieu, & Peter Goldman. (1988). Nitrosoimidazoles: highly bactericidal analogs of 5-nitroimidazole drugs. Journal of Medicinal Chemistry. 31(2). 323–329. 21 indexed citations

12.

Gittes, Ruben F., et al.. (1988). Nitrate production and phagocyte activation: differences among Sprague–Dawley, Wistar‐Furth and Lewis rats. Carcinogenesis. 9(4). 625–627. 21 indexed citations

13.

Ehlhardt, William J., Bernard B. Beaulieu, & Peter Goldman. (1988). Mammalian cell toxicity and bacterial mutagenicity of nitrosoimidazoles. Biochemical Pharmacology. 37(13). 2603–2606. 12 indexed citations

14.

Goldman, Peter, et al.. (1987). Role of the intestinal flora in the acetylation of sulfasalazine metabolites. Biochemical Pharmacology. 36(21). 3772–3774. 35 indexed citations

15.

Goldman, Peter. (1984). Effect of bioavailability on Dose-Response relationships. The American Journal of Medicine. 77(5). 47–51. 12 indexed citations

16.

Wheeler, Larry A., et al.. (1977). The effects of additional flora on the response of salmonella mutants lodged in the gastrointestinal tract.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(2). 451–5. 5 indexed citations

17.

Goldman, Peter, et al.. (1977). Properties of the Ames salmonella mutants lodged in the gastrointestinal tract of gnotobiotic rats. American Journal of Clinical Nutrition. 30(11). 1921–1926. 5 indexed citations

18.

Mitchell, Allen A., Frederick H. Lovejoy, & Peter Goldman. (1976). Drug ingestions associated with miosis in comatose children. The Journal of Pediatrics. 89(2). 303–305. 15 indexed citations

19.

Wheeler, Larry A., et al.. (1976). Association of salmonella mutants with germ-free rats: Characterization of the reverse mutational response to 2-nitrofluorene. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 41(2-3). 209–216. 7 indexed citations

20.

Wheeler, L. A., et al.. (1975). The relationship between nitro group reduction and the intestinal microflora.. Journal of Pharmacology and Experimental Therapeutics. 194(1). 135–144. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact